The glycemic control and rates of hypoglycemia were similar between the groups over the study period’s 5 days, with day 3 time in range (70-180 mg/dL) trending toward significance in the NPH group ( Table 2 ). 14 Seggelke et al 15 reported significantly lower premeal glucose levels over 3 days in posttransplant patients with cystic fibrosis-related diabetes (N = 20) receiving BBI with NPH given once daily with methylprednisolone than those in patients receiving BBI ( Table 2 ).
← all excerpts
Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review.
1
—
—